Abstract-Both 17␤-estradiol (E 2 ) and fibroblast growth factor-2 (FGF2) stimulate angiogenesis and endothelial cell migration and proliferation. The first goal of this study was to explore the potential link between this hormone and this growth factor. E 2 -stimulated angiogenesis in SC Matrigel plugs in Fgf2 ϩ/ϩ mice, but not in Fgf2 Ϫ/Ϫ mice. Cell cultures from subcutaneous Matrigel plugs demonstrated that E 2 increased both migration and proliferation in endothelial cells from Fgf2 ϩ/ϩ mice, but not from in Fgf2 Ϫ/Ϫ mice. Several isoforms of fibroblast growth factor-2 (FGF2) are expressed: the low molecular weight 18-kDa protein (FGF2 lmw ) is secreted and activates tyrosine kinase receptors (FGFRs), whereas the high molecular weight (21 and 22 kDa) isoforms (FGF2 hmw ) remains intranuclear, but their role is mainly unknown. The second goal of this study was to explore the respective roles of FGF2 isoforms in the effects of E 2 . We thus generated mice deficient only in the FGF2 lmw (Fgf2 lmwϪ/Ϫ ). E 2 stimulated in vivo angiogenesis and in vitro migration in endothelial cells from Fgf2 lmwϪ/Ϫ as it did in Fgf2 ϩ/ϩ mice. E 2 increased FGF2 hmw protein abundance in endothelial cell cultures from Fgf2 ϩ/ϩ and Fgf2 lmwϪ/Ϫ mice. As shown using siRNA transfection, these effects were FGFR independent but involved FGF2-Interacting Factor, an intracellular FGF2 hmw partner. This is the first report for a physiological role for the intracellular FGF2 hmw found to mediate the effect of E 2 on endothelial cell migration via an intracrine action. Key Words: mouse Ⅲ estradiol Ⅲ growth factor Ⅲ endothelium Ⅲ migration E ndothelium, being uniquely positioned at the interface between the blood and the vessel wall, plays a crucial role in the physiology of circulation by performing multiple functions. 1,2 It is involved in the regulation of coagulation, leukocyte adhesion in inflammation, transvascular flux of cells, liquids, and solutes, vessel tone, and vascular smooth muscle growth. Endothelium also constitutes a target for the sex hormone, 17␤-estradiol (E 2 ). Using a series of experimental models, E 2 has been reported to promote angiogenic activity and endothelial cell migration and proliferation. 3 The angiogenic effect is mediated through the estrogen receptor ␣ (ER␣). 4 However, the mechanisms involved downstream of ER␣ remain unclear. 5 Fibroblast growth factor-2 (FGF2) is an important mitogenic and angiogenic factor that stimulates endothelial cell growth and migration. Therefore, FGF2 could be a good candidate to be a partner of E 2 . However, FGF2 expression is complex because at least four (18, 22, 22.5, and 24 kDa) in human and three (18, 21, and 22 kDa) FGF2 isoforms in mouse are synthesized through the alternative use of translation initiation codons. 6 -9 These isoforms differ only in their NH 2 extremities, which confer a nuclear localization to the high molecular weight CUG-initiated (22, 22.5, 24 or 21, and 22 kDa) isoforms (FGF2 hmw ), whose function is mainly unknown. In contrast, the smaller 18-kDa AUG-initiated FGF2 isoform (FGF2 lmw ) is predominantly cytoplasmic, excreted, and stored in the extracellular matrix. 10 It stimulates cell proliferation and migration through binding to highaffinity transmembrane tyrosine kinase receptors (FGFR) and low-affinity receptors (heparan sulfate-containing proteoglycans), activating the mitogen-activated protein kinases (MAPKs) and/or phospholipase C-dependent pathways. Interestingly, E 2 has been reported to stimulate MAPK activity via an autocrine loop involving FGF2. 11 To achieve its proliferative activity, FGF2 needs to be internalized and translocated into the nucleus 12 during the G1 phase of the cell cycle. 13 In contrast, with the exception of human HSP 27-transfected endothelial cells, 14 FGF2
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hmw inhibited migration of endothelial cells by 50%, even in the presence of unrelated mitogens such as vascular endothelial growth factor (VEGF) and IGF-1 that promote cell migration. 20 Using specific antibodies, they localized the inhibition of migration to the amino-terminal end and stimulation of growth to the 18-kDa domain of 24-kDa FGF2. They concluded that 24-kDa FGF2 affects cell behavior differently than 18-kDa FGF2.
The goal of the present work was to analyze the role of FGF2 in E 2 -induced angiogenesis, and possibly, the specific involvement of the molecular isoforms of this growth factor. In a first set of experiments, we explored the angiogenic effect of E 2 in vivo in a mouse model of Matrigel plugs. The role of the FGF2 in the effect of E 2 on the migration and proliferation of the microvascular endothelial cells provided by the Matrigel plugs grown in culture was then studied. Using knockout mice disrupted for the Fgf2 gene (Fgf2 Ϫ/Ϫ ), 9 we demonstrated that endogenous FGF2 is absolutely required for the effects of E 2 . We also observed that E 2 affected the abundance of FGF receptors and FGF2 isoforms.
Using mice specifically deficient in the 18-kDa FGF2 
Materials and Methods

Animal Studies
FGF2
Ϫ/Ϫ mice were obtained as previously described. 9 To produce the Fgf2 lmw allele, the Hprt minigene in the tagged Fgf2 Ϫ allele was "exchanged" by gene targeting with a mutant exon 1 with the sequence CTGCAG replacing the wild-type CCATGC ( Figure 1A ). The mutant sequence encodes an alanine GCA in place of the methionine ATG translational start site of the 18-kDa low molecular isoform of FGF2. The adjacent upstream wobble base was also changed from C to T so that the composite of these three base changes generated a PstI site that is diagnostic for the exchanged allele. Cells with the exchanged allele were selected for the loss of HPRT function using 5 g/mL 6-thioguanine (Sigma), and the resulting ES cell line was injected into C57BL/6 blastocysts to generate germ-line chimeras. The germ-line chimeras were intercrossed with Black Swiss mice to generate Fgf2 lmwϩ/Ϫ mice. The colony was maintained as an advanced intercross line on a mixed 129/SvEvϫBlack Swiss background in order to avoid inadvertent recombinant inbreeding that can alter FGF2-deficient phenotypes. 21 Fgf2 lmwϪ/Ϫ mice were fertile and showed no obvious developmental defects. As expected, brain, aorta, and lung homogenates from Fgf2 lmwϪ/Ϫ mice expressed exclusively FGF2 hmw isoforms ( Figure  1B ). The background of Fgf2 ϩ/ϩ , Fgf2 Ϫ/Ϫ , and Fgf2 lmwϪ/Ϫ mice was a mixed genetic background 129/SvEv ϫ Black Swiss. 9 ER␣ Ϫ/Ϫ mice were previously described. 22 All mice (Fgf2
, and C57Bl/6) were ovariectomized at 4 weeks of age and implanted either with 60-day time-release E 2 pellets (0.1 mg E 2 , Innovative Research of America, ie, releasing 80 g/kg per day) SC into the back of the animals using a sterile trochar, or with placebo-releasing pellets.
At the time of euthanasia, serum was kept for hormone concentration measurement. Radioimmunoassay kits for E 2 were used following manufacturer instructions (Sorin Biomedica, Italy).
Angiogenesis
On day 10 after ovariectomy and placebo or E 2 treatment, the mice received a subcutaneous injection of Matrigel (0.5 mL) with 250 ng/mL FGF2. 23 After 7 more days, the animals were killed, and the Matrigel plugs were cautiously removed from of the envelope wrapping them, to prevent fibroblast contamination, and incubated in 1.5 mL of Matrisperse cell release solution (BD Biosciences) during 2 hours at 4°C. After dispersion from the gel, cells were counted using Malassey cell. Their characterization as endothelial cells is indicated in the next section. 
Endothelial Cell Cultures
Microvascular endothelial cells isolated as described were plated onto 5 g/cm 2 fibronectin-coated 35-mm dishes and cultured in Phenol-red-free Dulbecco's modified Eagle's medium (DMEM) supplemented with 10 mmol/L L-glutamine and 10% charcoalstripped fetal calf serum (CS-FCS) in a 10% CO 2 atmosphere. All studies were performed on cells before any passage. Cultured cells were characterized using three markers of endothelial cells: rabbit polyclonal anti-CD31 (BD Pharmingen), rabbit polyclonal anti-vWF (DAKO, Via real, California), or isolectin Bandeiraea simplicifolia B4 conjugated to FITC (Sigma-Aldrich). The three techniques constantly showed that endothelial cells represented Ն90% of the primary culture (data not shown).
When necessary, 5ϫ10 Ϫ8 mol/L of raloxifen (Eli Lilly), or 5ϫ10
Ϫ8
mol/L of ICI 182780 (Zeneca Pharmaceuticals) were incubated 30 minutes before E 2 treatment. Untreated control culture received only ethanol (1:1000 final).
Cell Migration Assays
Cells were plated onto 35-mm dishes and cultured to 90% confluence in 2 mL phenol-red-free DMEM, 10% CS-FCS. Scratch injury was applied using a tip. The debris were removed by washing the cells with PBS, and the cells were incubated for 8 hours in phenol-red-free DMEM 2% CS-FCS supplemented with E 2 (1 nmol/L) or FGF2 (3 ng/mL). The percentage of cell migration in vitro (ratio of the area that was recovered by migrating cells on area initially wounded, photographed with a Leica microscope) was determined using Leica Qwin standard V2.3 system. At least three experiments were performed. Mitogenic assay, DNA synthesis analysis, reverse transcription, and real-time quantitative PCR are described in the expanded Materials and Methods section available in the online data supplement at http://circres.ahajournals.org.
RT-PCR, Enzyme Analysis, and Southern Blotting of FGFRs
RT were performed with a common oligonucleotide of FGFRs: 5Ј-GAGATGGAGATGATGAAA-3Ј. PCR were performed using another set of oligonucleotide for FGFR1: 5Ј primer 5Ј-AGTAT-GGGAGCATCAACC, 3Ј primer 5Ј-TGAGGTCATCACAGCTGG, and for FGFR2 as previously described. 24 Fifty microliters of the PCR mixture was added along with the specific restriction enzymes for the following: FGFR1 IIIb, BstI; FGFR1 IIIc, AccI; FGFR2 IIIb, AvaI; and FGFR2 IIIc, EcoRV. Southern blotting were performed as previously described. 24, 25 The intensity of hybridization signals were quantified by densitometry using Phosphor Imager.
Transfection of Endothelial Cells With siRNA Duplexes
The 21-nucleotide siRNA duplexes were synthesized and purified by Dharmacon Research. The siRNA sequence targeting mouse Fif and Fgfr1 corresponded respectively to the coding region 951 to 972 and 1504 to 1525 relative to the first nucleotide at the start codon. The siRNA control was the scramble one from Dharmacon. The transfection was performed with 10 mol/L of siRNA and oligofectamine reagent (Invitrogen) according to the manufacturer's instructions.
Western Blotting
Proteins (30 g) were boiled for 2 minutes in a Laemmli's sample buffer solution and loaded onto 12.5% polyacrylamide gels containing SDS. They were transferred onto PVDF membrane and blocked in 3% nonfat milk TBST. Specific antibodies were used at a dilution of 1:1000. Polyclonal anti-FIF antibodies were generated as previously described. 15 Mouse monoclonal anti-FGF2 (Ab3) was from Oncogene Science, and rabbit polyclonal against ERK2 (C14) mouse monoclonal against the phospho p44/p42 MAPK (E10) were purchased from Cell Signaling. Monoclonal anti-␤-actin (AC-15) was from Sigma Aldrich, and monoclonal anti-SMN was from BD Biosciences. HRP-labeled secondary antibodies were revealed by the ECL system.
Specific ELISA for FGF2
FGF2 in supernatants of endothelial cells were quantified using standard sandwich ELISA (Quantikine FGF basic, R&D Systems Inc) following the manufacturer's instructions. The sensitivity of FGF2 assays was 10 pg/mL.
MAPK Activation
Endothelial cells were kept for 18 hours in serum-free medium. Cells were left untreated or stimulated with 3 ng/mL FGF2 during 10 minutes and then frozen before protein analysis. Proteins were separated on a 12.5% SDS-Polyacrylamide gel and subjected to immunoblotting with the indicated antibodies.
Statistics
Results are expressed as meanϮSEM. To test the respective role of E 2 treatment and of FGF2 genotypes, a two-factor ANOVA was performed (comparison of four groups). A value of PϽ0.05 was considered as statistically significant. When an interaction was observed between the two factors, the four groups were compared using a 1-factor ANOVA. The results of this test is also indicated by an asterisk when PϽ0.05 to facilitate the reading of the figures.
Results
Characterization of the Mouse Models and Generation of the Fgf2 lmw؊/؊ Mice
Ovariectomized mice implanted with a placebo pellet showed undetectable (Ͻ5 pg/mL, ie, 20ϫ10 Ϫ12 mol/L) circulating levels of E 2 , whereas those implanted with a pellet releasing 0.1 mg E 2 for 60 days (ie, 80 g/kg per day) showed serum E 2 concentrations 0.3 to 0.5 nmol/L, irrespective of the genotype (C57Bl/6, Fgf2 ϩ/ϩ , Fgf2 Ϫ/Ϫ , Fgf2 lmwϪ/Ϫ , or ER␣ Ϫ/Ϫ ). Similarly, ovariectomized placebo-treated mice showed an atrophied uterus (Ͻ20 mg), whereas E 2 -treated mice showed a significant increase in uterine weight irrespective of the genotype (not shown).
Role of ER␣ and FGF2 in the Effect of E 2 on In Vivo Angiogenesis
As previously described in an angiogenic model of exogenous FGF2-loaded Matrigel plugs, 4 we found that E 2 increased about 2-fold the number of endothelial cells in plugs from both C57Bl/6 and Fgf2 ϩ/ϩ mice, confirming the angiogenic effect of E 2 in this model (Figure 2 ). The angiogenic effect of E 2 was abolished in ER␣ Ϫ/Ϫ mice, 22 confirming in another model of ER␣ gene inactivation 22, 26 that ER␣ mediates the angiogenic effect of E 2 . The angiogenic effect of E 2 was abolished in Fgf2 Ϫ/Ϫ mice (Pϭ0.41, NS). In contrast, the angiogenic effect of E 2 in Fgf2 lmwϪ/Ϫ was similar to that observed in Fgf2 ϩ/ϩ mice ( Figure 2 ). Interestingly, the effect of E 2 on cell migration ( Figure 4C ), but not on 3 H-thymidine incorporation ( Figure 4D ), was intact in cells obtained from Fgf2 lmwϪ/Ϫ as well as the effect of exogenously added FGF2 and VEGF on both migration and 3 H-thymidine incorporation in these cells.
Role of ER␣ and FGF2 in the Effect of E 2 in Endothelial Cell Culture Experiments
Effect of E 2 on FGF2 Isoforms, FGF Receptors, and FGF Signalization
The effect of E 2 on FGF2 expression was then studied. As shown by Western blot analysis, untreated Fgf2 ϩ/ϩ endothelial cells expressed mainly the FGF2 lmw isoform, whereas E 2 treatment induced the FGF2 hmw protein expression ( Figure  5A ). As previously reported, 7 most of FGF2 hmw was located in the nuclear fraction of Fgf2 ϩ/ϩ endothelial cells, and as expected, FGF2
hmw was more abundant in nuclei from E 2 -treated endothelial cells than in untreated control (online Figure, available 
from FGF2
lmwϪ/Ϫ mice to the same extent as in Fgf2 ϩ/ϩ cells ( Figure 5B) .
Unexpectedly, the abundance of Fgf2 mRNA was decreased by E 2 treatment 2.5-fold in cultured endothelial cells ( Figure 5C ).
We then investigated the effect of E 2 on FGF receptor expression. mRNA from endothelial cells were reversetranscribed using a common oligonucleotide. The sequence coding the third immunoglobulin-like domain was amplified and restriction analysis was used to distinguish between the IIIb and IIIc variant of receptors ( Figure 6A ). We found that both FGFR1 and R2 are expressed in our primary cell cultures but essentially FGFR1 presented the splicing variant coding the FGF2 high affinity receptor isoform (FGFR1 IIIc) ( Figure 6A ). Using real-time PCR analysis, we showed that E 2 increased FGFR1 IIIc mRNA 1.8-fold in Fgf2 ϩ/ϩ and 2-fold in Fgf2 lmwϪ/Ϫ endothelial cells, whereas it has no effect on FGFR1 IIIc expression in Fgf2 Ϫ/Ϫ endothelial cells ( Figure 6B ). After determining the time course of FGF2-stimulated ERK phosphorylation in endothelial cells (Figure 7A ), we found that FGF2-sustained ERK phosphorylation could be efficiently prevented by siRNA Fgfr1 transfection ( Figure  7B ), demonstrating the functional efficacy of FGFR blockade and the predominance of FGFR1 in the signal transduction of FGF2 lmw . The Fgfr1 mRNA was significantly reduced after siRNA Fgfr1 transfection of endothelial cells ( Figure 7C ), but its blockade did not alter the E 2 -stimulated migration ( Figure  7D ), demonstrating the independence of E 2 -elicited migration from FGFR.
SMN was recently shown to specifically interact with FGF2 hmw . SMN mRNA and protein were found to be expressed in cultured endothelial cells but no change of SMN expression could be detected after E 2 -treatment ( Figure 8A and 8B). FIF was also recently found to be an intracellular partner of the HMW FGF2. 15 The abundance of Fif mRNA and protein were then assessed in cultured endothelial cells, and both were found to be increased on E 2 exposure ( Figure  8C and 8D) . The induction of FIF protein expression by E 2 was also altered by siRNA, resulting in 80% inhibition, whereas scramble siRNA had no significant effect ( Figure  8D ). The partial suppression of Fif induced an attenuation of the stimulating effect of E 2 on Fgf2 ϩ/ϩ cell migration and an 
Discussion
It is now clear that the effects of E 2 are not limited to the field of reproduction but have many extrareproductive effects, in particular in the pathophysiology of atherosclerosis 27 and in angiogenesis. 3, 28 Johns et al 4 have shown that ER␣ mediates the stimulating effect of E 2 on angiogenesis. In the present work, the angiogenic effect of E 2 was abolished in ER␣ Ϫ/Ϫ mice, 22 a model of complete ER␣ gene inactivation, 26 confirming that the ER␣ is required to mediate the angiogenic effect of E 2 , and the results of angiogenesis obtained in both transgenic models are valid. In addition, we found that the stimulating effect of E 2 on endothelial cell migration and proliferation was mediated by ER␣ and completely antagonized by raloxifene and ICI 182780. 29 Because no growth factor downstream of the ER␣ have been clearly identified to explain this effect, we investigated, in the present work, the role of FGF2, a potent angiogenic factor produced and secreted by endothelial cells, which promotes their migration, proliferation, chemotaxis, and protease production. Interestingly, in this model of Matrigel loaded with exogenous FGF2, basal angiogenesis was similar in Fgf2 ϩ/ϩ and in Fgf2 Ϫ/Ϫ mice, endogenous FGF2 not being required. In contrast, endogenous FGF2 appears absolutely required for the E 2 -induced acceleration of this process. We thus showed for the first time, that the regenerative properties of E 2 are dependent on endogenous FGF2.
We then explored the effect of E 2 on FGF2 isoforms. FGF2 isoforms are synthesized through an alternative use of translation initiation codons. [7] [8] [9] The smaller AUG-initiated FGF2 (FGF2 lmw , 18 kDa) is predominantly cytoplasmic, excreted, and stored in the extracellular matrix. 10 In the present work, we found that E 2 increased FGF2 hmw , but not FGF2 lmw , abundance in cultured mouse endothelial cells, and we were unable to detect secreted FGF2 in the supernatant of these cells. This suggests that E 2 specifically induces the expression of FGF2 hmw . At the same time, Fgf2 mRNA concentration decreases. Such a discrepancy has been previously reported by us in 3T3 cells 30 and others in erythroid cells. 31 This strongly suggests a regulation at the translational level. Indeed, when the pool of silent mRNA is mobilized by the ribosomal machinery, its translation could activate its instability, possibly by removing masking-protein able to protect the instability region. 31 Such a region has been clearly identified within the 3Ј end of Fgf2 mRNA. 32 Furthermore, we have previously identified a translational enhancer located at the end of the 3Ј UTR of the Fgf2 gene, the activation of which promotes a preferential increase of the FGF2 hmw forms. 33 These two phenomena involving the role of the 3Ј UTR of Fgf2 mRNA could explain the effect observed here after stimulation by E 2 .
FGF2 lmw is thought to stimulate proliferation and migration through tyrosine kinase receptors (FGFR), activating the MAPKs and/or phospholipase C-dependent pathways. The complex then translocates into the nucleus during the G1 phase of the cell cycle 13 by a mechanism in which translokin appears to play a key role 12 and is very distinct from the translocation of FGF2 hmw , which is nuclearized by the importin machinery. 8 Indeed, the nuclear localization sequence of the FGF2 hmw is responsible of their nuclear localization, but their function is mainly unknown.
We thus explored the effect of E 2 on the FGF receptors. We found that in mouse endothelial cells, FGFR1 IIIc and FGFR2 IIIb mRNA are expressed. E 2 increased 1.8-fold FGFR1 IIIc mRNA in Fgf2 ϩ/ϩ endothelial cells, whereas it had no effect in Fgf2 Ϫ/Ϫ endothelial cells. This suggests that an increase in FGFR1 signaling could have contributed to the effect of E 2 on angiogenesis, migration, and proliferation. However, as shown in Figure 7 , treatment of endothelial cells by siRNA against Fgfr1 reduces the level of its mRNA and fully inhibits both cell response as well as ERK phosphorylation in response to FGF2 stimulation, showing the dominant role of FGFR1 versus FGFR2 for MAPK activation. In these conditions, E 2 is still active, demonstrating that the receptordependent pathways are not required to relieve the E 2 effect.
The specific role of the FGF2 isoforms had previously been studied in various cell culture models but these studies provided conflicting data as recently pointed out by Boilly. 34 Estrogen was reported to promote proliferation and migration via the activation of p42/44 and p38 MAPK in porcine aortic endothelial cells 29 ; this activation was also reported to involve an autocrine loop by FGF2 lmw in cultured human endothelial cells. 11 In contrast, in a model of bovine aortic endothelial cells (BAECs) stably transfected with 27-kDa human HSP, but not in parental BAECs, FGF2 hmw was found to inhibit migration under the influence of E 2 by a mechanism involving activated MAPK and phosphorylated estrogen receptor. 14, 20 However, HSP27 protein expression was not altered by E 2 in primary culture of mouse endothelial cells (B. Garmy-Susini, unpublished data, 2004). This goes along with the fact that FGF2 hmw could not be detected in the supernatant of the cells. Until the present work, very little was actually known about FGF2 hmw mode of action. Thanks to the generation of mice deficient in FGF2 lmw , we were able to demonstrate for the first time that FGF2 hmw , is absolutely required for the stimulating effect of E 2 on endothelial cell migration, whereas FGF2 lmw appears dispensable for this effect ( Figure 4C ). However, both the intracrine FGF2 hmw pathway and the classical auto/paracrine FGF2 lmw pathway (including FGFR1 IIIc signaling) appear required to mediate the stimulating effect of E 2 on 3 H-thymidine incorporation ( Figure 4D ). FGF2 hmw has been shown to specifically interact with two mainly nuclear protein: FIF 15 and SMN. 16 SMN is essentially described as a key activator for snRNP assembly and recycling. The role of its association with FGF2 hmw is still unclear. In our hands, we did not detect any modulation of the cellular content of SMN after E 2 stimulation. Conversely, FIF expression was stimulated by E 2 and its proposed role is in accordance with our results: FIF has been previously identified as an antiapoptotic factor, 35 whose expression allows the synthesis of some matrix metalloproteases and the repression of TIMP-2. The functional role of FIF in cell migration was demonstrated in this study by the partial and complete abolition of the E 2 effect by Fif siRNA duplex in cells from Fgf2 ϩ/ϩ and Fgf2 lmwϪ/Ϫ mice, respectively.
The roles of FGF2 in many different systems, from brain and bone development, to arterial restenosis, vessel remodeling, differential functions of FGF2 and VEGF, fibrosis, wound healing, etc, coupled with the fact that there are FGF2 isoforms the functions of which are completely unknown but obviously important because they are conserved across species and their expression is differentially regulated across tissues, all make this gene and the function of its isoforms of considerable importance.
The present work demonstrates a novel link between FGF2 isoforms and estradiol in angiogenesis and endothelial cell migration and proliferation. Although the phenotype of Fgf2 Ϫ/Ϫ mice suggest a dispensable role of E 2 -dependent angiogenesis in the domains of reproduction and development, the present data should be taken into consideration in pathophysiological circumstances such as atherosclerosis, 36 collagen disease, 37 diabetic angiogenesis, 28 and possibly breast cancer, 38 where both FGF2 and E 2 have been suggested to be involved. 
